The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Insulin-like growth factor 1 (IGF-1): a growth hormone
Open accessAbstract
AIM: To contribute to the debate about whether growth hormone (GH) and insulin-like growth factor 1 (IGF-1) act independently on the growth process. METHODS: To describe growth in human and animal models of isolated IGF-1 deficiency (IGHD), such as in Laron syndrome (LS; primary IGF-1 deficiency and GH resistance) and IGF-1 gene or GH receptor gene knockout (KO) mice. RESULTS: Since the description of LS in 1966, 51 patients were followed, many since infancy. Newborns with LS are shorter (42-47 cm) than healthy babies (49-52 cm), suggesting that IGF-1 has some influence on intrauterine growth. Newborn mice with IGF-1 gene KO are 30% smaller. The postnatal growth rate of patients with LS is very slow, the distance from the lowest normal centile increasing progressively. If untreated, the final height is 100-136 cm for female and 109-138 cm for male patients. They have acromicia, organomicria including the brain, heart, gonads, genitalia, and retardation of skeletal maturation. The availability of biosynthetic IGF-1 since 1988 has enabled it to be administered to children with LS. It accelerated linear growth rates to 8-9 cm in the first year of treatment, compared with 10-12 cm/year during GH treatment of IGHD. The growth rate in following years was 5-6.5 cm/year. CONCLUSION: IGF-1 is an important growth hormone, mediating the protein anabolic and linear growth promoting effect of pituitary GH. It has a GH independent growth stimulating effect, which with respect to cartilage cells is possibly optimised by the synergistic action with GH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479
Rinderknecht, E., & Humbel, R. E. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40889-1 · Cited by 1,545
Molecular and Cellular Aspects of the Insulin-Like Growth Factor I Receptor
LEROITH, D., WERNER, H., BEITNER-JOHNSON, D., & ROBERTS, A. T. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-2-143 · Cited by 1,423
Woods, K. A., Camacho-Hübner, C., Savage, M. O., & Clark, A. J. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351805 · Cited by 1,085
A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro.
SALMON, W. D., & Daughaday, W. H. (1957) · PubMed · Cited by 1,084
The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily*
Hwa, V., Oh, Y., & Rosenfeld, R. G. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0382 · Cited by 1,079
Ohlsson, C., Bengtsson, B.-A., Isaksson, O. G. P., Andreassen, T. T., & Slootweg, M. C. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0324 · Cited by 855
Somatomedin: Proposed Designation for Sulphation Factor
DAUGHADAY, W. H., HALL, K., RABEN, M. S., SALMON, W. D., LEO VAN DEN BRANDE, J., & VAN WYK, J. J. (1972) · Nature · doi:10.1038/235107a0 · Cited by 842
Zhou, Y., Xu, B. C., Maheshwari, H. G., He, L., Reed, M., Lozykowski, M., Okada, S., Cataldo, L., Coschigamo, K., Wagner, T. E., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13215 · Cited by 802
Godowski, P. J., Leung, D. W., Meacham, L. R., Galgani, J. P., Hellmiss, R., Keret, R., Rotwein, P. S., Parks, J. S., Laron, Z., & Wood, W. I. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.8083 · Cited by 604
Self-citationInsulin-like growth factor I stimulates growth in hypophysectomized rats
Schoenle, E., Zapf, J., Humbel, R. E., & Froesch, E. R. (1982) · Nature · doi:10.1038/296252a0 · Cited by 596
Short-Term Metabolic Effects of Recombinant Human Insulin-like Growth Factor I in Healthy Adults
Guler, H.-P., Zapf, J., & Froesch, E. R. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707163170303 · Cited by 554
TANNENBAUM, G. S., & LING, N. (1984) · Endocrinology · doi:10.1210/endo-115-5-1952 · Cited by 524
A dual effector theory of growth-hormone action
Green, H., Morikawa, M., & Mxon, T. (1985) · Differentiation · doi:10.1111/j.1432-0436.1985.tb00316.x · Cited by 514
Evidence that somatomedin is synthesized by multiple tissues in the fetus
D'Ercole, A. J., Applewhite, G. T., & Underwood, L. E. (1980) · Developmental Biology · doi:10.1016/0012-1606(80)90166-9 · Cited by 437
Guler, H. P., Zapf, J., Scheiwiller, E., & Froesch, E. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.13.4889 · Cited by 422
Froesch, E. R., Bürgi, H., Ramseier, E. B., Bally, P., & Labhart, A. (1963) · Journal of Clinical Investigation · doi:10.1172/jci104866 · Cited by 419
Hormone families: pancreatic hormones and homologous growth factors
Blundell, T. L., & Humbel, R. E. (1980) · Nature · doi:10.1038/287781a0 · Cited by 377
Structure of the human insulin receptor gene and characterization of its promoter.
Seino, S., Seino, M., Nishi, S., & Bell, G. I. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.1.114 · Cited by 361
Laron, Z., Pertzelan, A., & Mannheimer, S. (1966) · PubMed · Cited by 345
Self-citationRinderknecht, E., & Humbel, R. E. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.7.2365 · Cited by 324
Bondy, C. A., Werner, H., Roberts, C. T., & LeRoith, D. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-9-1386 · Cited by 321
Regulation by Growth Hormone of Number of Chondrocytes Containing IGF-I in Rat Growth Plate
Nilsson, A., Isgaard, J., Lindahl, A., Dahlström, A., Skottner, A., & Isaksson, O. G. P. (1986) · Science · doi:10.1126/science.3523759 · Cited by 318
Laron Dwarfism and Mutations of the Growth Hormone–Receptor Gene
Amselem, S., Duquesnoy, P., Attree, O., Novelli, G., Bousnina, S., Postel-Vinay, M.-C., & Goossens, M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198910123211501 · Cited by 316
The IGF-I Receptor in Cancer Research
Baserga, R. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4667 · Cited by 292
Brissenden, J. E., Ullrich, A., & Francke, U. (1984) · Nature · doi:10.1038/310781a0 · Cited by 266
Structure, Evolution, Expression and Regulation of Insulin-Like Growth Factors I and II
Rotwein, P. (1991) · Growth Factors · doi:10.3109/08977199109000267 · Cited by 252
Bone homeostasis in growth hormone receptor–null mice is restored by IGF-I but independent of Stat5
Sims, N. A., Clément-Lacroix, P., Da Ponte, F., Bouali, Y., Binart, N., Moriggl, R., Goffin, V., Coschigano, K., Gaillard-Kelly, M., Kopchick, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10753 · Cited by 251
LARON, Z., PERTZELAN, A., KARP, M., KOWADLO-SILBERGELD, A., & DAUGHADAY, W. H. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-33-2-332 · Cited by 197
Self-citationGluckman, P. D., Gunn, A. J., Wray, A., Cutfield, W. S., Chatelain, P. G., Guilbaud, O., Ambler, G. R., Wilton, P., & Albertsson-Wikland, K. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80342-7 · Cited by 176
Pituitary dwarfism with high serum levels of growth hormone.
Laron, Z., Pertzelan, A., & Karp, M. (1968) · PubMed · Cited by 160
Self-citationKato, H., Faria, T. N., STANNARD, B. S., et al. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.1.7512194 · Cited by 145
Growth curves for Laron syndrome.
Laron, Z., Lilos, P., & Klinger, B. (1993) · Archives of Disease in Childhood · doi:10.1136/adc.68.6.768 · Cited by 123
Self-citationGuevara‐Aguirre, J., Rosenbloom, A. L., Vasconez, O., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3743 · Cited by 121
Long-Term Treatment of Growth Hormone Insensitivity Syndrome with IGF-I
Ranke, M. B., Savage, M. O., Chatelain, P. G., Preece, M. A., Rosenfeld, R. G., & Wilton, P. (1999) · Hormone Research in Paediatrics · doi:10.1159/000023345 · Cited by 120
Sjögren, K., Bohlooly, Y. M., Olsson, B., Coschigano, K. T., Törnell, J., Mohan, S., Isaksson, O. G. P., Baumann, G., Kopchick, J., & Ohlsson, C. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1986 · Cited by 120
Backeljauw, P. F., & Underwood, L. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784089 · Cited by 120
Three Year IGF-I Treatment of Children with Laron Syndrome
Klinger, B., & Laron, Z. (1995) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1995.8.3.149 · Cited by 116
Self-citationHolzenberger, M., Leneuve, P., Hamard, G., Ducos, B., Périn, L., Binoux, M., & Bouc, Y. L. (2000) · Endocrinology · doi:10.1210/endo.141.7.7550 · Cited by 111
Neuroendocrine control of growth hormone secretion in humans
Devesa, J., Lima, L., & Tresguerres, J. A. F. (1992) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(92)90168-z · Cited by 107
Laron-Type Dwarfism (Hereditary Somatomedin Deficiency): A Review
Laron, Z. (1984) · Springer eBooks · doi:10.1007/978-3-642-69070-9_3 · Cited by 106
Self-citationJaffe, C. A., Ho, P. J., DeMott-Friberg, R., Bowers, C. Y., & Barkan, A. L. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.7903313 · Cited by 102
The IGF system : molecular biology, physiology, and clinical applications
Roberts, C. T., & Rosenfeld, R. G. (1999) · Humana Press eBooks · Cited by 95
Insulin-Like Growth Factor I Improves Height in Growth Hormone Insensitivity: Two Years’ Results
Ranke, M. B., Savage, M. O., Chatelain, P., et al. (2008) · Hormone Research · doi:10.1159/000184637 · Cited by 95
Guevara‐Aguirre, J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.629 · Cited by 82
LEWITT, M. S., Saunders, H., Phuyal, J. L., & Baxter, R. C. (1994) · Endocrinology · doi:10.1210/endo.134.6.7514998 · Cited by 77
Laron, Z., Klinger, B., Jensen, L. T., & Erster, B. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03513.x · Cited by 72
Self-citationNiwa, M., Satô, S., Saito, Y., et al. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb26482.x · Cited by 66
Kanety, H., Karasik, A., Klinger, B., Silbergeld, A., & Laron, Z. (1993) · European Journal of Endocrinology · doi:10.1530/acta.0.1280144 · Cited by 59
Self-citationThe IGF System: Molecular Biology, Physiology, and Clinical Applications
Berry, M. T., & Unterman, T. G. (2000) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200002000-00045 · Cited by 57
Somatomedin-1 (Recombinant Insulin-Like Growth Factor-1)
Laron, Z. (1999) · BioDrugs · doi:10.2165/00063030-199911010-00006 · Cited by 49
Self-citationMullis, P. E., Patel, M. S., Brlckell, P. M., Hindmarsh, P. C., & Brook, C. G. D. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03765.x · Cited by 49
Accili, D., Nakae, J., Kim, J. J., Park, B. C., & Rother, K. I. (1999) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1999.12.4.475 · Cited by 49
Intravenous administration of recombinant IGF-I lowers serum GHRH and TSH
Laron, Z., Klinger, B., Silbergeld, A., Lewin, R., Erster, B., & Gil‐Ad, I. (1990) · European Journal of Endocrinology · doi:10.1530/acta.0.1230378 · Cited by 43
Self-citationFeinberg, M. S., Scheinowitz, M., & Laron, Z. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00642-6 · Cited by 35
Self-citationBrat, O., Ziv, I., Klinger, B., et al. (2008) · Hormone Research · doi:10.1159/000185429 · Cited by 34
Laron, Z., Suikkari, A., Klinger, B., Silbergeld, A., Pertzelan, A., Seppälä, M. T., & Koivisto, V. A. (1992) · European Journal of Endocrinology · doi:10.1530/acta.0.1270351 · Cited by 29
Self-citationInsulin‐Like Growth Factor I Actions on Somatic Growth
Zapf, J., & Froesch, E. R. (1999) · Comprehensive physiology · doi:10.1002/cphy.cp070521 · Cited by 28
Lessons from Laron syndrome (LS) 1966–1992
DeLamater, P. V. (1994) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(94)90020-5 · Cited by 25
(1999) · Humana Press eBooks · doi:10.1007/978-1-59259-698-0 · Cited by 23
Elimination Characteristics of Intravenously Administered rIGF-I in Laron-Type Dwarfs
Klinger, B., Garty, M., & Laron, Z. (2017) · Developmental Pharmacology and Therapeutics · doi:10.1159/000457646 · Cited by 22
Self-citationKlinger, B., Jensen, L. T., Silbergeld, A., & Laron, Z. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.7990809.x · Cited by 20
Self-citationUnderwood, L. E., & Backeljauw, P. F. (1993) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1993.tb01015.x · Cited by 3
Cited by
Grimberg, A., DiVall, S. A., Polychronakos, C., Allen, D. B., Cohen, L. E., Quintos, J. B., Rossi, W. C., Feudtner, C., Murad, M. H., & on behalf of the Drug and Therapeutics Committee and Ethics Committee of the Pediatric Endocrine Society (2016) · Hormone Research in Paediatrics · doi:10.1159/000452150 · Cited by 697
Yuan, R., Tsaih, S., Petkova, S. B., De Evsikova, C. M., Xing, S., Marion, M. A., Bogue, M. A., Mills, K. D., Peters, L. L., Bult, C. J., et al. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00478.x · Cited by 411
Comparison of Yeasts as Hosts for Recombinant Protein Production
Vieira Gomes, A. M., Souza Carmo, T., Silva Carvalho, L., Mendonça Bahia, F., & Parachin, N. S. (2018) · Microorganisms · doi:10.3390/microorganisms6020038 · Cited by 308
Dehkhoda, F., Lee, C. M. M., Medina, J., & Brooks, A. J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00035 · Cited by 304
Cellular and molecular mechanisms of intestinal fibrosis
Speca, S. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i28.3635 · Cited by 272
Metadata
- Authors
- Laron, Z.
- Venue
- Molecular Pathology
- Publisher
- BMJ
- Published
- 2001-10
- Volume
- 54
- Issue
- 5
- Pages
- 311-316
- ISSN
- 1366-8714 (ISSN-L)
- 1472-4154
- OpenAlex
- W1989308141
- Cited by
- 608
- References
- 63
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.